Santa Cruz Biotechnology

BCAR3 (3G4) | Santa Cruz Biotechnology

mouse monoclonal IgG2a; BCAR3 Antibody (3G4) is an IgG2a κ mouse monoclonal BCAR3 antibody (also designated BCAR3 antibody) that detects the BCAR3 protein of human origin by WB, IP and ELISA. BCAR3 Antibody (3G4) is available as the non-conjugated anti-BCAR3 antibody. BCAR3 (breast cancer anti-estrogen resistance 3, also designated AND-34 in murine; a novel SH2-containing protein 2 or NSP2, and SH2D3B) overexpression is a characteristic of antiestrogen resistance in human ZR-75-1 breast cancer cells. The deduced 825-amino acid BCAR3 protein contains a Src homology 2 (SH2) domain and shares homology to yeast CDC48. A 3.4-kb BCAR3 transcript is present in heart, placenta, skeletal muscle, spleen, prostate, testis, ovary, small intestine, colon, fetal kidney, and tamoxifen-resistant cancer cell lines. BCAR3 acts as a regulator of R-Ras to mediate the level of insulin receptor substrate 1 (IRS-1) in MCF-7 and ZR-75-1 breast cancer cell lines. BCAR3 also interacts with p130Cas to enhance Src activation and cell migration.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.